Document Type
Article
Publication Date
2-22-2017
Abstract
Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group)in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P
Recommended Citation
Xiong, DZ., Yuan, YR., Gao, R. et al. Clinical Observation On Palipeddone Sustained Release Tablet In The Treatment of Schizophrenia. Act Nerv Super 55, 146–150 (2013). https://doi.org/10.1007/BF03379733
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Title
Activitas Nervosa Superior
DOI
10.1007/BF03379733
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.